Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry.

Hannah Lois Kangleon-Tan Jongmin Sim Ji Young You Eun-Shin Lee Haemin Lee Sun Moon Yang Min-Ki Seong Eun Hwa Park Seok-Jin Nam Min-Ho Park Seok Won Lee Woo Chan Park Rogelio G Kangleon Crisostomo B Dy Soo Youn Bae Seung Pil Jungnull null

Published in: Annals of surgical treatment and research (2022)

Over the years, there has been a shift from CTx + HT to HT alone without a significant difference in OS. Therefore, HT alone could be a safe treatment option in selected patients, even those with T2N1 disease.

Keyphrases

epidermal growth factor receptor
end stage renal disease
tyrosine kinase
chronic kidney disease
endothelial cells
ejection fraction
newly diagnosed
squamous cell carcinoma
prognostic factors
peritoneal dialysis
patient reported outcomes
combination therapy
replacement therapy